Innospec Inc.(IOSP)Earnings, Financials & Key Ratios

IOSP•NASDAQ

$78.20

$1.94B mkt cap·16.7× P/E·Price updated May 6, 2026

SectorBasic Materials IndustrySpecialty Chemicals Sub-IndustrySpecialty additives and formulation chemicals

AboutInnospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company's Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.Show more

Revenue$1.78B-3.7%
EBITDA$206M-7.1%
Net Income$117M+227.5%
EPS (Diluted)4.67+228.9%
Gross Margin27.69%-5.9%
EBITDA Margin11.56%-3.6%
Operating Margin8.79%-8.8%
Net Margin6.56%+239.9%
ROE8.86%+194.3%
ROIC10.73%-21.1%
Debt/Equity0.06+71.1%

Technical→

IOSP Key Insights

Innospec Inc. (IOSP) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Company is almost debt free
✓Strong 5Y profit CAGR of 32.4%
✓12 consecutive years of dividend growth
✓Healthy dividend yield of 2.2%
✓Trading at only 1.4x book value

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

IOSP Price & Volume

Innospec Inc. (IOSP) stock price & volume — 10-year historical chart

Loading chart...

IOSP Growth Metrics

Innospec Inc. (IOSP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years5.79%

5 Years8.31%

3 Years-3.26%

TTM-3.65%

Profit CAGR

10 Years-0.25%

5 Years32.36%

3 Years-4.29%

TTM227.53%

EPS CAGR

10 Years-0.4%

5 Years32.12%

3 Years-4.25%

TTM234.29%

Return on Capital

10 Years11.43%

5 Years12.69%

3 Years12.32%

Last Year11.02%

IOSP Recent Earnings

Innospec Inc. (IOSP) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 10/12 qtrs (83%)●Beat Revenue 3/12 qtrs (25%)

Q1 2026Latest

Feb 17, 2026

EPS

$1.50

Est $1.26

+19.0%

Revenue

$456M

Est $461M

-1.1%

Q4 2025

Nov 4, 2025

EPS

$1.12

Est $1.03

+8.7%

Revenue

$442M

Est $461M

-4.1%

Q3 2025

Aug 5, 2025

EPS

$1.26

Est $1.17

+7.7%

Revenue

$440M

Est $450M

-2.3%

Q2 2025

May 8, 2025

EPS

$1.42

Est $1.40

+1.4%

Revenue

$441M

Est $468M

-5.7%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q1 2026Latest	Feb 17, 2026	$1.50vs $1.26+19.0%	$456Mvs $461M-1.1%
Q4 2025	Nov 4, 2025	$1.12vs $1.03+8.7%	$442Mvs $461M-4.1%
Q3 2025	Aug 5, 2025	$1.26vs $1.17+7.7%	$440Mvs $450M-2.3%
Q2 2025	May 8, 2025	$1.42vs $1.40+1.4%	$441Mvs $468M-5.7%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	FCF Yield	Debt / Equity
HWKNHawkins, Inc.Direct Competitor	3.46B	167.00	41.44	6.01%	7.75%	15.88%	2.02%	0.35
BCPCBalchem CorporationDirect Competitor	5.16B	161.13	33.92	8.75%	14.95%	12.38%	3.35%	0.15
ITICInvestors Title CompanyDirect Competitor	448.21M	237.40	12.78	5.6%	12.9%	13.19%	5.66%	0.06
KWRQuaker Chemical CorporationDirect Competitor	2.43B	140.10	-1000.71	2.66%	0.22%	0.31%	3.32%	0.67
CBTCabot CorporationDirect Competitor	4.12B	78.93	13.11	-7.04%	8.62%	18.55%	9.49%	0.71
ASIXAdvanSix Inc.Direct Competitor	868.26M	26.17	14.54	0.31%	3.24%	6.05%	0.74%	0.47
ALBAlbemarle CorporationProduct Competitor	22.93B	194.82	-33.82	-100%	-10.74%	-5.65%	3.02%
ECLEcolab Inc.Product Competitor	72.77B	257.65	35.39	2.16%	12.91%	21.96%	2.62%	0.96

Compare IOSP vs Peers

Innospec Inc. (IOSP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HWKN

Most directly comparable listed peer for IOSP.

Scale Benchmark

vs XOM

Larger-name benchmark to compare IOSP against a more recognizable public peer.

Peer Set

Compare Top 5

vs HWKN, BCPC, ITIC, KWR

IOSP Income Statement

Innospec Inc. (IOSP) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Sales/Revenue	1.31B	1.48B	1.51B	1.19B	1.48B	1.96B	1.95B	1.85B	1.78B
Revenue Growth %	47.93%	13.02%	2.46%	-21.16%	24.33%	32.38%	-0.76%	-5.31%	-3.65%
Cost of Goods Sold	903.5M	1.04B	1.05B	850.4M	1.05B	1.38B	1.36B	1.3B	1.29B
COGS % of Revenue	69.14%	70.55%	69.19%	71.28%	70.68%	70.12%	69.67%	70.58%	72.31%
Gross Profit	403.3M▲ 0%	435M▲ 7.9%	466.2M▲ 7.2%	342.7M▼ 26.5%	434.9M▲ 26.9%	586.7M▲ 34.9%	591.1M▲ 0.7%	542.9M▼ 8.2%	492.4M▼ 9.3%
Gross Margin %	30.86%	29.45%	30.81%	28.72%	29.32%	29.88%	30.33%	29.42%	27.69%
Gross Profit Growth %	21.37%	7.86%	7.17%	-26.49%	26.9%	34.9%	0.75%	-8.15%	-9.3%
Operating Expenses	270.9M	294.4M	316.3M	309M	302.8M	399.4M	429.5M	365M	336.1M
OpEx % of Revenue	20.73%	19.93%	20.9%	25.9%	20.41%	20.34%	22.04%	19.78%	18.9%
Selling, General & Admin	239.5M	261M	280.9M	237M	267.2M	360.7M	387.8M	314M	285.1M
SG&A % of Revenue	18.33%	17.67%	18.56%	19.86%	18.01%	18.37%	19.9%	17.02%	16.03%
Research & Development	31.4M	33.4M	35.4M	30.9M	37.4M	38.7M	41.7M	47.8M	51M
R&D % of Revenue	2.4%	2.26%	2.34%	2.59%	2.52%	1.97%	2.14%	2.59%	2.87%
Other Operating Expenses	0	0	0	41.1M	-1.8M	0	0	3.2M	0
Operating Income	129.7M▲ 0%	133.5M▲ 2.9%	149.9M▲ 12.3%	33.7M▼ 77.5%	132.1M▲ 292.0%	187.3M▲ 41.8%	161.6M▼ 13.7%	177.9M▲ 10.1%	156.3M▼ 12.1%
Operating Margin %	9.93%	9.04%	9.91%	2.82%	8.91%	9.54%	8.29%	9.64%	8.79%
Operating Income Growth %	23.05%	2.93%	12.28%	-77.52%	291.99%	41.79%	-13.72%	10.09%	-12.14%
EBITDA	185.3M	189.2M	200.9M	79.7M	174.8M	227.4M	200.9M	221.4M	205.6M
EBITDA Margin %	14.18%	12.81%	13.28%	6.68%	11.78%	11.58%	10.31%	12%	11.56%
EBITDA Growth %	29.49%	2.1%	6.18%	-60.33%	119.32%	30.09%	-11.65%	10.2%	-7.14%
D&A (Non-Cash Add-back)	55.6M	55.7M	51M	46M	42.7M	40.1M	39.3M	43.5M	49.3M
EBIT	136.3M	138.5M	155.2M	41.5M	130.3M	187.3M	161.6M	181.1M	156.3M
Net Interest Income	-8.2M	-6.9M	-4.8M	-1.8M	-1.5M	-1.1M	0	0	9.2M
Interest Income	0	0	0	0	0	0	0	0	9.2M
Interest Expense	8.2M	6.9M	4.8M	1.8M	1.5M	1.1M	0	0	0
Other Income/Expense	-4.3M	-1.9M	500K	6M	2.3M	-2.7M	12.8M	-136.7M	-18.2M
Pretax Income	128.1M▲ 0%	131.6M▲ 2.7%	150.4M▲ 14.3%	39.7M▼ 73.6%	134.4M▲ 238.5%	184.6M▲ 37.4%	174.4M▼ 5.5%	41.2M▼ 76.4%	138.1M▲ 235.2%
Pretax Margin %	9.8%	8.91%	9.94%	3.33%	9.06%	9.4%	8.95%	2.23%	7.77%
Income Tax	66.3M	46.6M	38.2M	11M	41.3M	51.6M	35.3M	5.6M	21.5M
Effective Tax Rate %	51.76%	35.41%	25.4%	27.71%	30.73%	27.95%	20.24%	13.59%	15.57%
Net Income	61.8M▲ 0%	85M▲ 37.5%	112.2M▲ 32.0%	28.7M▼ 74.4%	93.1M▲ 224.4%	133M▲ 42.9%	139.1M▲ 4.6%	35.6M▼ 74.4%	116.6M▲ 227.5%
Net Margin %	4.73%	5.76%	7.41%	2.41%	6.28%	6.77%	7.14%	1.93%	6.56%
Net Income Growth %	-23.99%	37.54%	32%	-74.42%	224.39%	42.86%	4.59%	-74.41%	227.53%
Net Income (Continuing)	61.8M	85M	112.2M	28.7M	93.1M	133M	139.1M	35.6M	116.6M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	400K	500K	400K	500K	600K	2.4M	2.5M	4.9M	6.8M
EPS (Diluted)	2.52▲ 0%	3.45▲ 36.9%	4.54▲ 31.6%	1.16▼ 74.4%	3.75▲ 223.3%	5.32▲ 41.9%	5.56▲ 4.5%	1.42▼ 74.5%	4.67▲ 228.9%
EPS Growth %	-24.32%	36.9%	31.59%	-74.45%	223.28%	41.87%	4.51%	-74.46%	228.87%
EPS (Basic)	2.56	3.48	4.58	1.17	3.78	5.37	5.60	1.43	4.69
Diluted Shares Outstanding	24.49M	24.6M	24.73M	24.78M	24.85M	24.98M	25.02M	25.12M	24.99M
Basic Shares Outstanding	24.15M	24.4M	24.48M	24.56M	24.65M	24.79M	24.85M	24.93M	24.88M
Dividend Payout Ratio	30.1%	25.53%	22.28%	89.2%	30.93%	23.83%	25.23%	108.99%	36.36%

IOSP Balance Sheet

Innospec Inc. (IOSP) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Total Current Assets	561.5M	663.9M	630.3M	566.2M	728.1M	872.6M	885.7M	956.6M	1B
Cash & Short-Term Investments	90.2M	123.1M	75.7M	105.3M	141.8M	147.1M	203.7M	289.2M	292.5M
Cash Only	90.2M	123.1M	75.7M	105.3M	141.8M	147.1M	203.7M	289.2M	292.5M
Short-Term Investments	0	0	0	0	0	0	0	0	0
Accounts Receivable	244.5M	279.7M	292M	221.4M	284.5M	334.6M	359.8M	341.7M	342.3M
Days Sales Outstanding	68.29	69.12	70.43	67.73	70	62.19	67.39	67.58	70.27
Inventory	209.8M	248M	244.6M	220M	277.6M	373.1M	300.1M	301M	329.3M
Days Inventory Outstanding	84.76	86.88	85.26	94.43	96.64	98.9	80.68	84.35	93.49
Other Current Assets	1.1M	0	800K	400K	400K	400K	600K	600K	40.5M
Total Non-Current Assets	848.7M	809.5M	838.5M	831.2M	842.8M	731.1M	821.7M	778.1M	827.8M
Property, Plant & Equipment	196M	196.4M	231.1M	250.9M	249.8M	266.2M	313.4M	314.5M	338.8M
Fixed Asset Turnover	6.67x	7.52x	6.55x	4.76x	5.94x	7.38x	6.22x	5.87x	5.25x
Goodwill	361.8M	364.9M	363M	371.2M	364.3M	358.8M	399.3M	382.5M	399M
Intangible Assets	163.3M	136.3M	113.5M	75.3M	57.5M	45M	57.3M	65.4M	67.7M
Long-Term Investments	116M	95.9M	0	0	0	0	0	0	0
Other Non-Current Assets	5.1M	7.2M	121.8M	126.2M	164.8M	55.2M	41.3M	6.3M	8.7M
Total Assets	1.41B▲ 0%	1.47B▲ 4.5%	1.47B▼ 0.3%	1.4B▼ 4.9%	1.57B▲ 12.4%	1.6B▲ 2.1%	1.71B▲ 6.5%	1.73B▲ 1.6%	1.83B▲ 5.6%
Asset Turnover	0.93x	1.00x	1.03x	0.85x	0.94x	1.22x	1.14x	1.06x	0.97x
Asset Growth %	19.37%	4.48%	-0.31%	-4.86%	12.42%	2.09%	6.47%	1.6%	5.63%
Total Current Liabilities	261.6M	296.6M	303.5M	252.4M	336.6M	405.8M	371.5M	371.4M	360.1M
Accounts Payable	117.9M	126.8M	122M	98.7M	148.7M	165.3M	163.6M	163.8M	174.7M
Days Payables Outstanding	47.63	44.42	42.53	42.36	51.76	43.82	43.98	45.9	49.6
Short-Term Debt	15.8M	21.4M	0	0	0	0	0	0	15.9M
Deferred Revenue (Current)	100K	8.6M	0	0	0	0	0	0	0
Other Current Liabilities	5.1M	5.9M	5.6M	6.6M	5.2M	5.3M	5.8M	5M	164.2M
Current Ratio	2.15x	2.24x	2.08x	2.24x	2.16x	2.15x	2.38x	2.58x	2.79x
Quick Ratio	1.34x	1.40x	1.27x	1.37x	1.34x	1.23x	1.58x	1.77x	1.88x
Cash Conversion Cycle	105.42	111.58	113.17	119.8	114.88	117.27	104.08	106.03	114.16
Total Non-Current Liabilities	354.3M	351.3M	246.4M	200.1M	201.3M	157.5M	186.3M	147.2M	55.9M
Long-Term Debt	202.6M	186.2M	58.6M	0	0	0	0	0	36.8M
Capital Lease Obligations	3.2M	1.5M	22.4M	29M	23.1M	31.4M	31.6M	31M	36.8M
Deferred Tax Liabilities	45M	48.2M	49.6M	46.9M	60.8M	26.2M	33.5M	23.5M	19.1M
Other Non-Current Liabilities	103.1M	115.4M	115.8M	124.2M	117.4M	99.9M	121.2M	92.7M	-36.8M
Total Liabilities	615.9M	647.9M	549.9M	452.5M	537.9M	563.3M	557.8M	518.6M	416M
Total Debt	224.3M	210.9M	92.6M	40.8M	35.6M	45.3M	45.2M	44.9M	89.5M
Net Debt	134.1M	87.8M	16.9M	-64.5M	-106.2M	-101.8M	-158.5M	-244.3M	-203M
Debt / Equity	0.28x	0.26x	0.10x	0.04x	0.03x	0.04x	0.04x	0.04x	0.06x
Debt / EBITDA	1.21x	1.11x	0.46x	0.51x	0.20x	0.20x	0.22x	0.20x	0.44x
Net Debt / EBITDA	0.72x	0.46x	0.08x	-0.81x	-0.61x	-0.45x	-0.79x	-1.10x	-0.99x
Interest Coverage	15.82x	19.35x	31.23x	18.72x	88.07x	170.27x	-	-	-
Total Equity	794.7M▲ 0%	826M▲ 3.9%	918.9M▲ 11.2%	944.9M▲ 2.8%	1.03B▲ 9.3%	1.04B▲ 0.7%	1.15B▲ 10.5%	1.22B▲ 5.8%	1.42B▲ 16.5%
Equity Growth %	21.5%	3.94%	11.25%	2.83%	9.32%	0.72%	10.5%	5.78%	16.47%
Book Value per Share	32.46	33.57	37.16	38.13	41.56	41.65	45.94	48.41	56.67
Total Shareholders' Equity	794.3M	825.5M	918.5M	944.4M	1.03B	1.04B	1.15B	1.21B	1.33B
Common Stock	300K	300K	300K	300K	300K	300K	300K	300K	300K
Retained Earnings	605M	668.3M	755.5M	758.6M	822.9M	924.2M	1.03B	1.02B	1.1B
Treasury Stock	-93.3M	-92.8M	-93.3M	-93.3M	-90.6M	-95.4M	-94.3M	-93M	-115.2M
Accumulated OCI	-38.5M	-75.7M	-74.4M	-57.3M	-46.9M	-145.2M	-148.1M	-91M	-34.7M
Minority Interest	400K	500K	400K	500K	600K	2.4M	2.5M	4.9M	6.8M

IOSP Cash Flow Statement

Innospec Inc. (IOSP) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Cash from Operations	82.7M	104.9M	161.6M	145.9M	93.2M	81.7M	207.3M	184.5M	138.3M
Operating CF Margin %	6.33%	7.1%	10.68%	12.23%	6.28%	4.16%	10.64%	10%	7.78%
Operating CF Growth %	-20.86%	26.84%	54.05%	-9.72%	-36.12%	-12.34%	153.73%	-11%	-25.04%
Net Income	61.8M	85M	112.2M	28.7M	93.1M	133M	139.1M	35.6M	116.6M
Depreciation & Amortization	50.4M	49.6M	47.6M	46M	42.7M	40.1M	39.3M	43.5M	43.6M
Stock-Based Compensation	4.1M	4.9M	26.7M	5.8M	4.4M	6.7M	8M	8.5M	8.1M
Deferred Taxes	-6.7M	5.5M	0	-2.5M	6.4M	-5.5M	3.6M	-39.3M	-10.2M
Other Non-Cash Items	-1.9M	-5.3M	-4.1M	17.8M	-5.3M	-2.5M	-3.3M	155.1M	-19.8M
Working Capital Changes	-25M	-34.8M	-20.8M	50.1M	-48.1M	-90.1M	20.6M	-18.9M	0
Change in Receivables	-83.2M	-45.7M	-18.2M	10.1M	-31.4M	-55.5M	-12.6M	4.3M	0
Change in Inventory	-30.8M	-42.2M	2.4M	25.5M	-62M	-98.5M	83M	-11.8M	0
Change in Payables	48.6M	38.4M	0	-45.9M	90.2M	54.2M	-26.9M	-4.5M	0
Cash from Investing	-29.6M	-35.5M	-31M	-29.7M	-36.2M	-42.1M	-111.8M	-62M	-75.1M
Capital Expenditures	-32.2M	-30.1M	-29.9M	-29.7M	-39.1M	-42.3M	-77.2M	-62.3M	-50.3M
CapEx % of Revenue	2.46%	2.04%	1.98%	2.49%	2.64%	2.15%	3.96%	3.38%	2.83%
Acquisitions	2.6M	-5.4M	0	100K	3M	2M	-34.7M	-200K	-700K
Investments	-	-	-	-	-	-	-	-	-
Other Investing	-8.9M	-1.2M	-1.1M	-100K	-100K	-1.8M	100K	500K	-24.1M
Cash from Financing	-66.4M	-36.2M	-177.9M	-86.8M	-20M	-33.7M	-39M	-35.3M	-63.9M
Debt Issued (Net)	-53.5M	-14.2M	-150.2M	-61.1M	-600K	-100K	-2.3M	0	0
Equity Issued (Net)	1000K	-300K	-1000K	100K	1000K	-1000K	-200K	1000K	0
Dividends Paid	-18.6M	-21.7M	-25M	-25.6M	-28.8M	-31.7M	-35.1M	-38.8M	-42.4M
Share Repurchases	-1.1M	-1.4M	-2.4M	-2.1M	-800K	-5.9M	-1.1M	-700K	0
Other Financing	0	0	-300K	-200K	100K	1.8M	-1.4M	2.1M	-21.5M
Net Change in Cash	-11.7M▲ 0%	32.9M▲ 381.2%	-47.4M▼ 244.1%	29.6M▲ 162.4%	36.5M▲ 23.3%	5.3M▼ 85.5%	56.6M▲ 967.9%	85.5M▲ 51.1%	3.3M▼ 96.1%
Free Cash Flow	50.5M▲ 0%	74.8M▲ 48.1%	131.7M▲ 76.1%	116.2M▼ 11.8%	54.1M▼ 53.4%	39.4M▼ 27.2%	145.2M▲ 268.5%	143.1M▼ 1.4%	88M▼ 38.5%
FCF Margin %	3.86%	5.06%	8.7%	9.74%	3.65%	2.01%	7.45%	7.75%	4.95%
FCF Growth %	-42.61%	48.12%	76.07%	-11.77%	-53.44%	-27.17%	268.53%	-1.45%	-38.5%
FCF per Share	2.06	3.04	5.33	4.69	2.18	1.58	5.80	5.70	3.52
FCF Conversion (FCF/Net Income)	1.34x	1.23x	1.44x	5.08x	1.00x	0.61x	1.49x	5.18x	1.19x
Interest Paid	0	0	4.8M	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0

IOSP Key Ratios

Innospec Inc. (IOSP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	12.91%	8.53%	10.49%	12.86%	3.08%	9.41%	12.83%	12.7%	3.01%	8.86%
Return on Invested Capital (ROIC)	11.05%	11.09%	10.87%	12.16%	2.78%	10.96%	15.06%	12.56%	13.59%	10.73%
Gross Margin	37.62%	30.86%	29.45%	30.81%	28.72%	29.32%	29.88%	30.33%	29.42%	27.69%
Net Margin	9.2%	4.73%	5.76%	7.41%	2.41%	6.28%	6.77%	7.14%	1.93%	6.56%
Debt / Equity	0.42x	0.28x	0.26x	0.10x	0.04x	0.03x	0.04x	0.04x	0.04x	0.06x
Interest Coverage	32.94x	15.82x	19.35x	31.23x	18.72x	88.07x	170.27x	-	-	-
FCF Conversion	1.29x	1.34x	1.23x	1.44x	5.08x	1.00x	0.61x	1.49x	5.18x	1.19x
Revenue Growth	-12.73%	47.93%	13.02%	2.46%	-21.16%	24.33%	32.38%	-0.76%	-5.31%	-3.65%

IOSP SEC Filings & Documents

Innospec Inc. (IOSP) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Feb 18, 2026·SEC

Material company update

Nov 5, 2025·SEC

Material company update

Aug 6, 2025·SEC

10-K Annual Reports

FY 2026

Feb 18, 2026·SEC

FY 2025

Feb 19, 2025·SEC

FY 2024

Feb 14, 2024·SEC

10-Q Quarterly Reports

FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

FY 2025

May 9, 2025·SEC

IOSP Frequently Asked Questions

Innospec Inc. (IOSP) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Innospec Inc. (IOSP) reported $1.78B in revenue for fiscal year 2025. This represents a 282% increase from $465.0M in 1998.

Innospec Inc. (IOSP) saw revenue decline by 3.7% over the past year.

Yes, Innospec Inc. (IOSP) is profitable, generating $116.6M in net income for fiscal year 2025 (6.6% net margin).

Dividend & Returns

Yes, Innospec Inc. (IOSP) pays a dividend with a yield of 2.17%. This makes it attractive for income-focused investors.

Innospec Inc. (IOSP) has a return on equity (ROE) of 8.9%. This is below average, suggesting room for improvement.

Innospec Inc. (IOSP) generated $88.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More IOSP

Innospec Inc. (IOSP) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Innospec Inc.(IOSP)Earnings, Financials & Key Ratios

IOSP Key Insights

✓Strengths

✗Weaknesses

IOSP Price & Volume

IOSP Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

IOSP Recent Earnings

IOSP Peer Comparison

Compare IOSP vs Peers

vs HWKN

vs XOM

Compare Top 5

IOSP Income Statement

IOSP Balance Sheet

IOSP Cash Flow Statement

IOSP Key Ratios

IOSP SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

IOSP Frequently Asked Questions

Explore More IOSP

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation